Acetylated therapeutic procytotoxins
View Patent ↗A class of procytotoxic agents is characterized by a capability to kill with target cell-specificity. Such an aspect can be a pore-forming protein which has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group, and an acetyl group. These agents are useful in treating cancer, especially prostate cancer.
1. A procytotoxin comprising a peptide that comprises at least one lysine residue bound via a peptide bond to at least one acetylated amino acid via the ε-amino group of said lysine residue, wherein said peptide without said modification is a cytotoxic peptide, and wherein said at least one acetylated amino acid bound via the ε-amino group of said lysine residue acts to prevent the peptide from forming a lytically active conformation, wherein the cytotoxic peptide is a pore-forming cytolytic peptide.
2. The procytotoxin of claim 1 , wherein the pore-forming cytolytic peptide is selected from the group consisting of Ae I, cytolysin of sea anemone, aerolysin, amatoxin, amoebapore, amoebapore homolog from Entamoeba dispar , brevinin-1E, brevinin-2E, barbatolysin, cytolysin of Enterococcus faecalis , delta hemolysin, diphtheria toxin, E1Tor cytolysin of Vibrio cholerae , equinatoxin, enterotoxin of Aeromonas hydrophila , esculentin, granulysin, haemolysin of Vibrio parahaemolyticus , intermedilysin of Streptococcus intermedius , the lentivirus lytic peptide, leukotoxin of Actinobacillus actinomycetemcomitans , magainin, melittin, membrane-associated lymphotoxin, Met-enkephalin, neokyotorphin, neokyotorphin fragment 1, neokyotorphin fragment 2, neokyotorphin fragment 3, neokyotorphin fragment 4, NK-lysin, paradaxin, perform, perfringolysin O of Clostridium perfringens , phallolysin, phallotoxin, and streptolysin.
3. The procytotoxin of claim 2 , wherein the cytolytic peptide is an amoebapore.
4. The procytotoxin of claim 3 , having the following structure: Gly-Phe-Ile-Ala-Thr-Leu-Cys-Thr-Lys{R}-Val-Leu-Asp-Phe-Gly-Ile-Asp-Lys{R}-Leu-Ile-Gln-Leu-Ile-Glu-Asp-Lys {R} (SEQ ID NO: 1), wherein at least one {R} is independently selected from the group consisting of [ε-γ]-Glu-Ac and [ε-γ]-Glu-[α-γ]-(Glu) 1-3 -Ac (SEQ ID NO: 11), wherein: [ε-γ] represents a peptide bond between the epsilon amino group of lysine and the gamma carboxyl group of the adjacent glutamate and [α-γ] represents a peptide bond between the alpha amino group of the first glutamate and the gamma carboxyl group of the second glutamate, the subscript indicates that additional numbers of the designated amino acid can be linked to the first via conventional peptide bonds, and Ac represents an acetyl group bound to the free amino group of the last glutamate.
5. The procytotoxin of claim 2 , wherein the cytolytic peptide is a melittin.
6. The procytotoxin of claim 5 consisting essentially of the following structure: Gly-Ile-Gly-Ala-Val-Leu-Lys{R}-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys {R}-Arg-Lys{R}-Arg-Gln-Gln (SEQ ID NO: 2), wherein at least one {R} is independently selected from the group consisting of [ε-γ]-Glu-Ac and [ε-γ]-Glu-[α-γ]-(Glu) 1-3 -Ac (SEQ ID NO: 11), wherein: [ε-γ] represents a peptide bond between the epsilon amino group of lysine and the gamma carboxyl group of the adjacent glutamate, [α-γ] represents a peptide bond between the alpha amino group of the first glutamate and the gamma carboxyl group of the second glutamate, the subscript indicates that additional numbers of the designated amino acid can be linked to the first via conventional peptide bonds, and Ac represents an acetyl group bound to the free amino group of the last glutamate.
7. A procytotoxin comprising a peptide having at least one lysine residue bound via a peptide bond to at least one amino acid via the ε-amino group of said lysine residue, wherein said peptide without said modification is a cytotoxic peptide, and wherein said at least one amino acid bound via the ε-amino group of said lysine residue acts to prevent the peptide from forming a lytically active conformation, and wherein said procytotoxin has a structure selected from the group consisting of: N-Gly-Phe-Ile-Ala-Thr-Leu-Cys-Thr-Lys-Val-Leu-Asp-Phe-Gly-Ile-Asp-Lys-Leu-Ile-Gln-Leu-Ile-Glu-Asp-Lys-{[ε-γ]-Glu-[α-γ]-Glu-Ac}-CONH 2 (SEQ ID NO: 8) and NH 2 -Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys{[ε-γ]-Glu-[α-γ]-Glu-Ac}-Arg-Lys-{[ε-γ]-Glu-[α-ε]-Glu-Ac}-Arg-Gln-Gln-COOH (SEQ ID NO: 10).
8. A pharmaceutical composition, comprising the procytotoxin of claim 1 , and a pharmaceutically acceptable excipient.
9. A method for selectively destroying a target cell, comprising contacting the target cell with a procytotoxin, which comprises a cytotoxic peptide having at least one lysine residue bound via a peptide bond to at least one acetylated amino acid via the ε-amino group of said lysine residue, wherein the cell is a cancer cell and wherein the cytotoxic peptide is a pore-forming cytolytic peptide.
10. The method of claim 9 , wherein said cancer cell is selected from the group consisting of prostate, ovarian, lung and skin cells.
11. The method of claim 9 , wherein the pore-forming cytolytic peptide is selected from the group consisting of Ae I, cytolysin of sea anemone, aerolysin, amatoxin, amoebapore, amoebapore homolog from Entamoeba dispar , brevinin-1E, brevinin-2E, barbatolysin, cytolysin of Enterococcus faecalis , delta hemolysin, diphtheria toxin, El Tor cytolysin of Vibrio cholerae , equinatoxin, enterotoxin of Aeromonas hydrophila , esculentin, granulysin, haemolysin of Vibrio parahaemolyticus , intermedilysin of Streptococcus intermedius , the lentivirus lytic peptide, leukotoxin of Actinobacillus actinomycetemcomitans , magainin, melittin, membrane-associated lymphotoxin, Met-enkephalin, neokyotorphin, neokyotorphin fragment 1, neokyotorphin fragment 2, neokyotorphin fragment 3, neokyotorphin fragment 4, NK-lysin, paradaxin, perform, perfringolysin O, theta-toxin, of Clostridium perfringens , phallolysin, phallotoxin, and streptolysin.
12. he method of claim 11 , wherein the cytolytic peptide is an amoebapore.
13. The method of claim , wherein the procytotoxin has the following structure: Gly-Phe-Ile-Ala-Thr-Leu-Cys-Thr-Lys {R}-Val-Leu-Asp-Phe-Gly-Ile-Asp-Lys {R}-Leu-Ile-Gln-Leu-Ile-Glu-Asp-Lys{R} (SEQ ID NO: 1), wherein at least one {R} is independently selected from the group consisting of [ε-γ]-Glu-Ac and [ε-γ]-Glu-[α-ε]-(Glu) 1-3 -Ac (SEQ ID NO: 11), wherein: [ε-γ] represents a peptide bond between the epsilon amino group of lysine and the gamma carboxyl group of the adjacent glutamate, [α-ε] represents a peptide bond between the alpha amino group of the first glutamate and the gamma carboxyl group of the second glutamate, the subscript indicates that additional numbers of the designated amino acid can be linked to the first via conventional peptide bonds, and Ac represents an acetyl group bound to the free amino group of the last glutamate.
14. The method of claim 11 , wherein the cytolytic peptide is a melittin.
15. The method of claim 14 , wherein the procytotoxin consisting essentially of the following structure: Gly-Ile-Gly-Ala-Val-Leu-Lys{R}-Val-Leu-Thr- Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys{R}-Arg-Lys{R}-Arg-Gln-Gln (SEQ ID NO: 2), wherein at least one {R}is independently selected from the group consisting of-[ε-γ]-Glu-Ac and [ε-γ]-Glu-[α-γ]-(Glu) 1-3 -Ac (SEQ ID NO: 11), wherein: [ε-γ] represents a peptide bond between the epsilon amino group of lysine and the gamma carboxyl group of the adjacent glutamate, [α-γ] represents a peptide bond between the alpha amino group of the first glutamate and the gamma carboxyl group of the second glutamate, the subscript indicates that additional numbers of the designated amino acid can be linked to the first via conventional peptide bonds and Ac represents an acetyl group bound to the free amino group of the last glutamate.
16. A method for selectively destroying a target cell, comprising contacting the target cell with a procytotoxin, which comprises a cytotoxic peptide having at least one lysine residue bound via a peptide bond to at least one amino acid via the ε-amino group of said lysine residue, wherein the cell is a cancer cell and the procytotoxin has the structure NH 2 -Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-{[ε-γ]-Glu-[α-γ]-Glu-Ac}-Arg-Lys-{[ε-γ]-Glu-[α-ε]-Glu-Ac}-Arg-Gln-Gln-COOH (SEQ ID NO: 10).
17. The procytotoxin of claim 1 , wherein the pore-forming cytolytic peptide is selected from the group consisting of Ae I, cytolysin of sea anemone, aerolysin, amatoxin, amoebapore, amoebapore homolog from Entamoeba dispar , brevinin-1E, brevinin-2E, barbatolysin, cytolysin of Enterococcus faecalis , delta hemolysin, diphtheria toxin, El Tor cytolysin of Vibrio cholerae , equinatoxin, enterotoxin of Aeromonas hydrophila , esculentin, granulysin, haemolysin of Vibrio parahaemolyticus , intermedilysin of Streptococcus intermedius , the lentivirus lytic peptide, leukotoxin of Actinobacillus actinomycetemcomitans , magainin, melittin, membrane-associated lymphotoxin, Met-enkephalin, neokyotorphin, neokyotorphin fragment 1, neokyotorphin fragment 2, neokyotorphin fragment 3, neokyotorphin fragment 4, NK-lysin, paradaxin, perform, perfringolysin O of Clostridium perfringens, phallolysin, phallotoxin, and streptolysin.
18. The procytotoxin of claim 17 , wherein the cytolytic peptide is an amoebapore.
19. The procytotoxin of claim 18 , having the following structure: Gly-Phe-Ile-Ala-Thr-Leu-Cys-Thr-Lys{R}-Val-Leu-Asp-Phe-Gly-Ile-Asp-Lys{R}-Leu-Ile-Gln-Leu-Ile-Glu-Asp-Lys{R} (SEQ ID NO: 1), wherein at least one {R} is independently selected from the group consisting of [ε-γ]-Glu-Ac and [ε-γ]-Glu-[α-ε]-(Glu) 1-3 -Ac (SEQ ID NO: 11), wherein [ε-γ] represents a peptide bond between the epsilon amino group of lysine and the gamma carboxyl group of the adjacent glutamate, [α-ε] represents a peptide bond between the alpha amino group of the first glutamate and the gamma carboxyl group of the second glutamate, the subscript indicates that additional numbers of the designated amino acid can be linked to the first via conventional peptide bonds, and Ac represents an acetyl group bound to the free amino group of the last glutamate.
20. A method for selectively destroying a target cell, comprising contacting the target cell with a procytotoxin, which comprises a cytotoxic peptide having at least one lysine residue bound via a peptide bond to at least one amino acid via the ε-amino group of said lysine residue, wherein the cell is a cancer cell and the procytotoxin has the structure N-Gly-Phe-Ile-Ala-Thr-Leu-Cys-Thr-Lys-Val-Leu-Asp-Phe-Gly-Ile-Asp-Lys-Leu-Ile-Gln-Leu-Ile-Glu-Asp-Lys-{[ε-γ]-Glu-[α-ε]-Glu-Ac}-CONH 2 (SEQ ID NO: 8).
21. A procytotoxin comprising a peptide having at least one lysine residue bound via a peptide bond to at least one- amino acid via the ε-amino group of said lysine residue,
(i) wherein said peptide without the modification is a cytolytic peptide,
(ii) wherein said at least one amino acid bound via the ε-amino group of said lysine residue acts to prevent the peptide from forming a lytically active conformation, and
(iii) wherein said cytolytic peptide need not be internalized to cause target-specific cell death.
22. The procytotoxin of claim 21 , wherein the cytolytic peptide is selected from the group consisting of amoebapore and melittin.